SGLT2 inhibitors × kidney outcomes

TrialDiabetes technology & therapeutics2018

Effect of Canagliflozin on Urinary Albumin Excretion in Japanese Patients with Type 2 Diabetes Mellitus and Microalbuminuria: A Pilot Study.

Takeshi Osonoi et al.PubMed ↗Full text ↗Publisher ↗

What the trial testedas reported · 2018

Not counted

Probably lowered kidney outcomes

−42.0percentage points−57.0 to −21.9

As reported

difference −42.0 %, 95% CI −57.0 to −21.9

One number in the abstract

the abstract, start to end

The urinary albumin level decreased by 42.0% (95% confidence interval:

← favours treatmentfavours comparator →
could be chance
Kidney outcomes
−42.0−57.0 to −21.9
SGLT2 inhibitorsKidney outcomes
1 / 3

15 papers cite it

2018
2019
2020
2021
2022
2023
2024
2025
2026
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 30096243